MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Radiofrequency Lesioning for hemidystonia: a systematic review

A. Abdulbaki, A. Jijakli, P. Doshi, J. Krauss (Hannover, Germany)

Meeting: 2024 International Congress

Abstract Number: 1105

Keywords: Dystonia: Treatment, Pallidotomy, Thalamotomy

Category: Surgical Therapy: Other Movement Disorders

Objective: The aim of this systematic review is to summarize published reports on RL for hemidystonia and to evaluate clinical outcome.

Background: Radiofrequency lesioning (RL) has been a mainstay in functional neurosurgery to treat dystonic movement disorders, which was replaced by deep brain stimulation (DBS) in the late 1990s. Studies on RL have shown variable benefit in patients with hemidystonia.

Method: A systematic literature review was performed according to PRISMA guidelines in PubMed, Embase, and Web of Science using a customized software (UiPath, NY) to identify all case reports, case series, and cohort studies reporting patients with hemidystonia treated with RF. Manuscripts were then automatically searched for the search term “hemidystonia”. The selected manuscripts were manually screened to identify appropriate reports.

Results: More than 20 reports were identified with 118 cases published between the years 1962 – 2022. Thalamotomy was performed in 88 cases, pallidotomy in 27 cases, and both in the remaining 3 cases. Until 1998, improvement in hemidystonia was not quantified using standard rating scale. Qualitatively good improvement was reported in 18/39 (50%) patients with hemidystonia after thalamotomy. In addition, newer reports indicated a 35% benefit in BFMDRS total score in 7 patients and 60% in 15 patients, respectively. With respect to pallidotomy, 4/8 (50%) patients for whom individual patient data were available were classified as responders, when considering a 30% cut-off for improvement. The lack of a standardized assessment of the results contributes to the difficulty in interpreting the outcome.

Conclusion: With recent advances in targeting methods, RL may be reconsidered as a treatment option for hemidystonia as an alternative to DBS. Further studies with standardized assessment of outcomes are needed to better characterize variability in outcome and to identify prognostic factors.

To cite this abstract in AMA style:

A. Abdulbaki, A. Jijakli, P. Doshi, J. Krauss. Radiofrequency Lesioning for hemidystonia: a systematic review [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/radiofrequency-lesioning-for-hemidystonia-a-systematic-review/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/radiofrequency-lesioning-for-hemidystonia-a-systematic-review/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley